Terbinafine Stella Cream skin cream 1% (10g) treatment of fungal infections in the skin, tinea versicolor

Dosage form Tube
Specifications Terbinafine hydrochloride

Ingredient

Composition information	Content
Terbinafine hydrochloride	1% w/w

Uses

indications

Terbinafine Stella Cream 1% is indicated in the following cases:

The treatment of fungal infections in the skin caused by Trichophyton (such as T.rubrum, T.mentagrophytes, T.verrucosum, T.Violaceum), Microsporum Canis and Epidermophyton Flocosum.

Treatment of yeast infections in the skin, mainly caused by Candida (such as C. Albicans).

terbinafine is an Alxylamine with broad spectrum antifungal activity, at low concentrations of terbinafine to kill skin fungus, mold and a few bipolar mushrooms. The activity of killing yeast or killing fungi depending on the species.

terbinafine prevents the sterol biosynthesis of mushrooms in the early stages. This leads to an Ergosterol deficiency and accumulates squalen in cells. The result is fungal cell death. Terbinafine acts by inhibiting Squalen Epoxidase in the fungal cell membrane.

enzyme Squalen Epoxidase is not related to the cytochrom P450 system. Terbinafine does not affect the metabolism of hormones as well as other drugs.

Dynamic pharmacokinetics

less than 5% of the dose is absorbed after applying the skin in humans; Therefore, the whole body effect is very small.

Before taking Terbinafine Stella Cream skin cream 1% (10g) treatment of fungal infections in the skin, tinea versicolor

How to use

Clean and completely dry the contaminated skin before applying Terbinafine cream.

Apply the cream to the contaminated skin and around with a thin layer and gently rub. In the case of an impetigo infection (interstitial breast, interstitial limbs, buttocks, groin), can be covered on the drug a thin gauze, especially in the evening.

Dosage

Terbinafine Stella Cream 1% Use on skin 1 or 2 times daily.

Treatment time:

Foot fungus, inguinal mushrooms: 1 to 2 weeks.

Interstitial mushrooms: 1 week.

Candida fungus in the skin: 2 weeks.

Visit: 2 weeks.

Clinical symptoms usually decrease within a few days. Unprecedent use or early treatment leads to the risk of recurrence. If there is no sign of improvement after 2 weeks, it should be diagnosed again.

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.

What to do when overdose?

In an emergency, call the 115 emergency center immediately or go to the nearest local health station.

Overdose treatment includes elimination of drugs, first of all for active carbon, then symptomatic support treatment if necessary.

What to do when you forget a dose?

If you forget a dose, use it as soon as possible. However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Note that it should not be used double the prescribed dose.

Side Effects

When using Terbinafine Stella Cream 1%, you may experience unwanted effects (ADR).

Common, 1/100

Skin: Peeling, itching.

Uncommon, 1/1,000

Skin: Skin damage, psoriasis, skin disorders, skin pigmentation disorders, erythema, burning skin, aches, pain at the place of application, irritation.

Rare, 1/10,000

Eye: eye irritation.

skin: dry skin, contact dermatitis , eczema .

Unknown frequency

Skin: Hypersensitivity, hypersensitivity.

Instructions on how to handle ADR

When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

contraindicated

Terbinafine Stella Cream 1% contraindicated in the following cases: allergies to Terbinafine or any excipient ingredients in the cream.

Caution when using

cream is only used on the skin.

Do not let the cream come into contact with the eyes, used in the vagina or drink. Also, avoid contact with nose, mouth and other mucous membranes.

Patients avoid wearing tight or bandaging clothes if not prescribed by a doctor.

Like other antifungal drugs, Terbinafine is not indicated for nail -related infections.

The safety and effectiveness of terbinafine in children under 12 years old has not been determined.

Terbinafine Stella Cream 1% has EMULCire 61 WL 2659 excipient containing Cetyl Alcohol, which can cause skin allergies at the place where the drug is used (eg contact dermatitis).

Terbinafine Stella Cream 1% contains ester derivatives of parahydroxybenzoate (such as methyl parahydroxybenzoate and propyl parahydroxybenzoate) potentially causing allergies (can occur slowly).

The ability to drive and operate machinery

Terbinafine cream does not affect the ability to drive or operate machinery.

Pregnancy

There is no clinical experience with terbinafine cream in pregnant women, so it is not advisable to use Terbinatine cream during pregnancy, unless the benefits are higher than the risk of hidden injection.

The period of breastfeeding

terbinafine excreted into breast milk, so the mother should not apply Terbinatine cream while breastfeeding. Do not give babies exposed to any treated skin, including the breast.

Interactive drug

unknown drug interactions of ice cream terbinafine.

Due to the absence of studies on the correlation of the drug, not mixing this drug with other drugs.

Storage

Store in closed packaging, dry place, avoid light. The temperature does not exceed 30 ° C.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.